Therefore, this study aimed to investigate whether PTEN promoter methylation level and PTEN expression in tumor tissue can predict long-term outcomes after TAM adjuvant therapy in patients with early breast cancer (EBC). This evidence concerns the gene PTEN and breast carcinoma.